Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Scilex Pharmaceuticals Gets Backing From Itochu Chemical Frontier | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Scilex Pharmaceuticals Gets Backing From Itochu Chemical Frontier

Investment by ICF is its first in a US pharma company

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Scilex Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, announced that Itochu Chemical Frontier Corporation (ICF) of Tokyo, Japan, and a member of Itochu Corporation, one of the three leading general trading companies in Japan, has made a strategic investment in Scilex. ICF has worked closely with Scilex as an advisor and development partner for its flagship product under development, ZTlid, since 2013. This investment by ICF is its first in a U.S. pharmaceutical company and makes ICF Scilex’s largest investor.

“Scilex has identified a niche in which it can be globally competitive and we are excited by the company’s potential,” ICF’s pharmaceutical division director and managing executive officer Toshinari Hidekuma said. “We look forward to working together further, to bring ZTlido’s unique patch delivery system to the market.”

Remarking on the partnership, Scilex co-founder and chief executive officer Anthony Mack said, “We are delighted to have the endorsement of a globally recognized strategic partner. Partnering with ICF will enable us to draw on their deep networks and expertise to help develop and commercialize our products in a global marketplace.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics